# PERIGON Pivotal Trial

Study · id `cardio:ct-nct02088554` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02088554](<https://clinicaltrials.gov/study/NCT02088554>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02088554

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1312 participants.

## Technical summary

Registry record NCT02088554. Allocation not applicable; no masking; primary purpose treatment. Start 2014-05-12 (actual); primary completion 2023-04-17 (actual). Results posted on 2024-06-04.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1312 participants (enrolled count; ClinicalTrials.gov record NCT02088554, source copy `cardio:ctgov-nct02088554-2026-04-29`, retrieved 2026-10-26)
- Started: 2014-05-12 (actual) (ClinicalTrials.gov record NCT02088554, source copy `cardio:ctgov-nct02088554-2026-04-29`, retrieved 2026-10-26)
- Primary completion: 2023-04-17 (actual) (ClinicalTrials.gov record NCT02088554, source copy `cardio:ctgov-nct02088554-2026-04-29`, retrieved 2026-10-26)
- Completion: 2035-12-31 (anticipated) (ClinicalTrials.gov record NCT02088554, source copy `cardio:ctgov-nct02088554-2026-04-29`, retrieved 2026-10-26)
- Results first posted: 2024-06-04 (ClinicalTrials.gov record NCT02088554, source copy `cardio:ctgov-nct02088554-2026-04-29`, retrieved 2026-10-26)
- Countries: United States; Canada; France; Germany; Italy; Netherlands; Switzerland; United Kingdom (ClinicalTrials.gov record NCT02088554, source copy `cardio:ctgov-nct02088554-2026-04-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02088554-2026-04-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: PERIGON Pivotal Trial
- Acronym: PERIGON
- Condition: Aortic Stenosis
- Intervention (Device): Model 400 aortic valve bioprosthesis
- Lead sponsor: Medtronic Cardiac Surgery
- Lead sponsor class: INDUSTRY
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Surgery (`cardio:org-medtronic-cardiac-surgery`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

## Provenance

Content hash: d70e431f8eb27b1392ce06244888bf4b1aa91050e40a9c4ae8092e563d0aa8f3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
